The purpose of this study is to determine the performance of a genetic assay, GemART, in cumulus cells predictive of embryo viability, and pregnancy success in women undergoing in vitro fertilization (IVF). Performance is defined as success rate per embryo transferred, as measured by the implantation rate of embryos transferred.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Enrollment
133
Embryos selected for transfer will be based upon morphology alone.
Embryos selected for transfer will be based upon morphology and GemART assay.
Reproductive Medicine Institute
Oak Brook, Illinois, United States
IVF Indiana
Indianapolis, Indiana, United States
University of Iowa
Iowa City, Iowa, United States
Reproductive Medicine Associates of Michigan
Troy, Michigan, United States
Clinical pregnancy rate
Clinical pregnancy, recorded as either positive or negative, will be determined using vaginal ultrasound during post-transfer week 4-9. Clinical Pregnancy rate for embryos selected using the GemART assay in conjunction with morphology will be compared with clinical pregnancy rate for embryos selected using morphology alone.
Time frame: Recorded at post-transfer week 4-9
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.